PIII Director Receives 2,000 RSU Award; Vesting in One Year

Rhea-AI Filing Summary

P3 Health Partners Inc. reported a director-level equity award: Jeffrey G. Park was granted 2,000 restricted stock units (RSUs) under the company's 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock and the RSUs vest one year from the grant date. The grant was recorded as an acquisition at a $0 price and the filing shows 218,561 shares beneficially owned by the reporting person following the award, held in a direct form of ownership. This filing documents a routine equity-based compensation event for a director, specifying award mechanics and post-grant holdings.

Positive

• Grant of 2,000 RSUs explicitly recorded under the 2021 Incentive Award Plan
• Each RSU equals one share, providing a clear conversion mechanism
• RSUs vest in one year, providing a defined vesting schedule
• Post-transaction direct beneficial ownership of 218,561 shares is disclosed

Negative

• None.

Insights

Financial Analyst

TL;DR: Director Jeffrey G. Park received 2,000 RSUs, increasing direct holdings to 218,561 shares; the grant appears routine.

The Form 4 shows a grant (transaction code A) of 2,000 RSUs under the 2021 Incentive Award Plan, with each RSU convertible into one share and a one-year vesting period. The grant was recorded at $0, consistent with a standard restricted award rather than a cash purchase. After the award the reporting person directly beneficially owns 218,561 shares. Relative to the reported holding, the award is small in absolute terms but documents continued executive/director equity exposure.

Corporate Governance Expert

TL;DR: Standard director equity award via RSUs with one-year vesting; disclosed on a Form 4 as required.

The disclosure identifies the award instrument (RSUs), the governing plan (P3 Health Partners Inc. 2021 Incentive Award Plan) and the vesting schedule (one year). The filing indicates the reporting person is a Director and that ownership following the grant is 218,561 shares (direct). This provides transparency on director compensation and current direct holdings without indicating additional governance actions or transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Park Jeffrey G

(Last) (First) (Middle)

C/O P3 HEALTH PARTNERS INC.

2370 CORPORATE CIRCLE, SUITE 300

(Street)

HENDERSON NV 89074

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
P3 Health Partners Inc. [ PIII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/06/2025		A		2,000(1)	A	$0	218,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant.

Remarks:

	/s/Todd Smith, Chief Legal Officer, as attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jeffrey G. Park report on Form 4 for P3 Health Partners (PIII)?

The Form 4 reports a grant of 2,000 restricted stock units (RSUs) to Jeffrey G. Park and shows 218,561 shares beneficially owned following the transaction.

How many RSUs were granted and what is the vesting schedule?

The grant is for 2,000 RSUs, each representing a right to one share, and the RSUs vest one year from the grant date.

Was there a purchase price for the RSU award?

The award is recorded with a $0 price, indicating a grant rather than a cash purchase.

What is the reporting person's relationship to P3 Health Partners?

The filing lists the reporting person, Jeffrey G. Park, as a Director of P3 Health Partners Inc.

Under which plan were the RSUs granted?

The RSUs were granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan.